Jpmorgan Chase & CO Replimune Group, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Replimune Group, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 486,609 shares of REPL stock, worth $5.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
486,609
Previous 249,349 95.15%
Holding current value
$5.27 Million
Previous $2.73 Million 115.67%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$10.54 - $14.93 $2.5 Million - $3.54 Million
237,260 Added 95.15%
486,609 $5.89 Million
Q3 2024

Dec 26, 2024
BUY
$8.09 - $11.23 $65,318 - $90,671
8,074 Added 3.35%
249,349 $2.73 Million
Q3 2024

Nov 08, 2024
BUY
$8.09 - $11.23 $65,318 - $90,671
8,074 Added 3.35%
249,349 $2.73 Million
Q2 2024

Dec 26, 2024
SELL
$5.01 - $9.46 $40,450 - $76,380
-8,074 Reduced 3.24%
241,275 $2.17 Million
Q2 2024

Aug 12, 2024
SELL
$5.01 - $9.46 $154,598 - $291,916
-30,858 Reduced 11.34%
241,275 $2.17 Million
Q1 2024

Dec 26, 2024
BUY
$6.87 - $9.31 $156,526 - $212,119
22,784 Added 9.14%
272,133 $2.22 Million
Q1 2024

May 10, 2024
SELL
$6.87 - $9.31 $225,954 - $306,205
-32,890 Reduced 10.78%
272,133 $2.22 Million
Q4 2023

Dec 26, 2024
BUY
$6.75 - $16.18 $375,799 - $900,805
55,674 Added 22.33%
305,023 $2.57 Million
Q4 2023

Feb 12, 2024
SELL
$6.75 - $16.18 $523,206 - $1.25 Million
-77,512 Reduced 20.26%
305,023 $2.57 Million
Q3 2023

Nov 14, 2023
BUY
$15.96 - $22.18 $1.27 Million - $1.77 Million
79,616 Added 26.28%
382,535 $6.55 Million
Q2 2023

Aug 11, 2023
BUY
$15.65 - $24.1 $2.19 Million - $3.37 Million
139,709 Added 85.6%
302,919 $7.03 Million
Q1 2023

May 18, 2023
BUY
$17.48 - $29.09 $940,214 - $1.56 Million
53,788 Added 49.16%
163,210 $2.88 Million
Q1 2023

May 11, 2023
SELL
$17.48 - $29.09 $756,359 - $1.26 Million
-43,270 Reduced 28.34%
109,422 $1.93 Million
Q4 2022

Feb 13, 2023
SELL
$17.09 - $27.91 $208,139 - $339,915
-12,179 Reduced 7.39%
152,692 $4.15 Million
Q3 2022

Nov 14, 2022
BUY
$15.6 - $21.15 $2.11 Million - $2.86 Million
135,173 Added 455.16%
164,871 $2.85 Million
Q2 2022

Aug 11, 2022
BUY
$13.32 - $19.98 $129,736 - $194,605
9,740 Added 48.8%
29,698 $519,000
Q1 2022

May 11, 2022
SELL
$15.24 - $29.75 $5.51 Million - $10.8 Million
-361,718 Reduced 94.77%
19,958 $339,000
Q4 2021

Feb 10, 2022
SELL
$25.43 - $34.25 $667,664 - $899,233
-26,255 Reduced 6.44%
381,676 $10.3 Million
Q3 2021

Nov 12, 2021
BUY
$28.98 - $39.54 $11.8 Million - $16.1 Million
407,931 New
407,931 $12.1 Million

Others Institutions Holding REPL

# of Institutions
161
Shares Held
74.9M
Call Options Held
38.4K
Put Options Held
43.7K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $533M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email